Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of prostate
|
1082 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.050 | 0.600 | 5 | 2010 | 2018 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.050 | 1.000 | 5 | 2012 | 2018 | ||||
Malignant tumor of cervix
|
245 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.050 | 1.000 | 5 | 2011 | 2019 | ||||
Prostate carcinoma
|
1168 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.050 | 0.600 | 5 | 2010 | 2018 | ||||
Psoriasis
|
705 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.050 | 1.000 | 5 | 2014 | 2019 | ||||
Squamous cell carcinoma
|
257 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.050 | 1.000 | 5 | 2012 | 2017 | ||||
Squamous cell carcinoma of the head and neck
|
348 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.050 | 0.800 | 5 | 2010 | 2017 | ||||
Carcinogenesis
|
355 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 0.750 | 4 | 2011 | 2014 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 0.750 | 4 | 2015 | 2018 | ||||
Hypertensive disease
|
1085 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 1.000 | 4 | 2015 | 2016 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 0.750 | 4 | 2013 | 2017 | ||||
Malignant neoplasm of gastrointestinal tract
|
55 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 1.000 | 4 | 2011 | 2014 | ||||
Multiple Sclerosis
|
1022 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 0.750 | 4 | 2011 | 2019 | ||||
Nasopharyngeal carcinoma
|
320 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 1.000 | 4 | 2013 | 2018 | ||||
Papillary thyroid carcinoma
|
204 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 0.750 | 4 | 2008 | 2018 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.040 | 0.750 | 4 | 2010 | 2019 | ||||
Behcet Syndrome
|
243 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.030 | 1.000 | 3 | 2014 | 2019 | ||||
Cerebrovascular accident
|
591 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.030 | 1.000 | 3 | 2014 | 2017 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.030 | 0.667 | 3 | 2014 | 2019 | ||||
Coronary Arteriosclerosis
|
440 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.030 | 1.000 | 3 | 2015 | 2017 | ||||
Diabetes
|
710 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.030 | 0.667 | 3 | 2014 | 2019 | ||||
Hepatitis B
|
519 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.030 | 0.667 | 3 | 2016 | 2019 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.030 | 1.000 | 3 | 2011 | 2014 | ||||
Ulcerative Colitis
|
827 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.030 | 1.000 | 3 | 2011 | 2018 | ||||
Acute GVH disease
|
49 | 0.447 | 0.880 | 5 | 160485411 | mature miRNA variant | C/G | snv | 0.71; 4.1E-06 | 0.70 | 0.020 | 1.000 | 2 | 2014 | 2019 |